disulfiram has been researched along with Prostatic Hyperplasia in 1 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "With the extracts of prostates with benign prostatic hyperplasia the pI 4." | 1.28 | Human prostatic aldehyde dehydrogenase of healthy controls and diseased prostates. ( Ambroziak, W; Ryzlak, MT; Schaffner, CP, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryzlak, MT | 1 |
| Ambroziak, W | 1 |
| Schaffner, CP | 1 |
1 other study available for disulfiram and Prostatic Hyperplasia
| Article | Year |
|---|---|
Human prostatic aldehyde dehydrogenase of healthy controls and diseased prostates.
Topics: Aged; Aldehyde Dehydrogenase; Aldehydes; Blotting, Western; Cytosol; Disulfiram; Glutathione Transfe | 1992 |